Peraso Reports Q4 & Full Year 2025 Results; Discloses Going Concern Risk Amid Revenue Decline
PRSO has more than doubled off its 52-week low of $0.52 on elevated volume (4.3× avg).
Summary
Peraso Inc. reported declining Q4 and full-year 2025 revenues and disclosed a "going concern" risk, highlighting significant financial challenges despite growth in its mmWave product segment.
Key Events · Earnings and Guidance · PRSO
-
Going Concern Warning
The company explicitly disclosed substantial doubt about its ability to continue as a going concern and its need to raise additional capital to fund operations.
-
Revenue Decline
Total net revenue for Q4 2025 decreased to $2.9 million from $3.7 million year-over-year, and full-year 2025 revenue fell to $12.2 million from $14.6 million in 2024.
-
Mixed Profitability
While GAAP net loss improved for both Q4 and full year, non-GAAP net loss worsened in Q4 2025 to $1.2 million from $0.5 million, and Adjusted EBITDA also declined in Q4 to negative $1.1 million from negative $0.4 million year-over-year.
-
mmWave Product Growth
Full-year mmWave product revenue increased six-fold over 2024, and the company secured multiple design wins, indicating progress in its core technology.
Analysis · PRSO · Manufacturing
This filing is critical due to the explicit disclosure of a "going concern" risk, indicating substantial doubt about the company's ability to continue operations without raising additional capital. While the company reported a reduced GAAP net loss for the full year, both Q4 and full-year revenues declined significantly, primarily due to lower memory IC product shipments. The growth in mmWave product revenue is a positive, but it was not enough to offset the overall revenue decline or prevent a worsening of Q4 non-GAAP profitability and Adjusted EBITDA. Investors should be highly concerned about the company's financial stability and its ability to secure necessary funding.
At the time of this filing, PRSO was trading at $1.61 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $17.5M. The 52-week trading range was $0.52 to $2.37. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.